BML-210 is the novel HDAC inhibitor, and its mechanism of action has not been characterized.
Product Name: BML-210(CAY10433) |Catalog Number: DC8660 |CAS 537034-17-6 |Other names: BML210; BML 210,CAY10433,CAY-10433,CAY 10433 |Chemical Name: |Molecule Formular: C20H25N3O2 |MW: 339.43
BML-210 is the novel HDAC inhibitor, and its mechanism of action has not been characterized.In vitro: Cell cycle analysis indicated that HeLa cell treatment with 20 and 30 μM concentration of BML-210 increased the proportion of cells in G0/G1 phase, and caused accumulation in subG1, indicating that the cells are undergoing apoptosis. BML-210 inhibits the growth of NB4 cells in dose- and time-dependent manner.
For research and scientific purpose only, not for human use!
没有评论:
发表评论